Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06482450 · ClinicalTrials.gov registry record · NA
Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support
A NA study of Vaccine Hesitancy and Vaccine Refusal, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Recruiting
- Registry status
- NA
- Development phase
- 1,200
- Enrollment target
- 1
- Study location
NCT06482450: Recruiting NA study of Vaccine Hesitancy and Vaccine Refusal, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT06482450 is a NA study of Vaccine Hesitancy and Vaccine Refusal that is actively recruiting participants, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 1,200 participants, above the 1,080-participant average among 5 other Vaccine Hesitancy trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06482450, a NA study of Vaccine Hesitancy and Vaccine Refusal, is actively recruiting participants, sponsored by Johns Hopkins Bloomberg School of Public Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to establish the technical feasibility of a scalable, integrated platform to improve patient informed decision-making and increase vaccine uptake and to evaluate the effectiveness of the integrated platform to improve vaccine uptake.
Primary Outcome
Proportion of vaccines due that are administered at the index appointment
Conditions Studied
Interventions
- OTHER LetsTalkShots (patient-facing CDS)
- OTHER LetsTalkShots (provider-facing CDS)
- OTHER Appointment Reminder Message
Study Locations (1)
Georgia
- Children's Healthcare of Atlanta Hughes Spalding Primary Care Clinic - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2025-06-11 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06482450 shows while recruiting
NCT06482450 is an interventional study that assigns participants to a tested intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, above the 1,080-participant average among 5 other Vaccine Hesitancy trials with a reported enrollment target (11% higher).
The record links to 2 conditions, with Vaccine Hesitancy appearing as the primary indexed condition, and to 3 interventions - of which LetsTalkShots (patient-facing CDS) is the first listed.
NCT06482450 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06482450 about?
NCT06482450 is a clinical study titled "Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support". The goal of this project is to establish the technical feasibility of a scalable, integrated platform to improve patient informed decision-making and increase vaccine uptake and to evaluate the effectiveness of the integrated platform to improve vaccine uptake.
What is the current status of trial NCT06482450?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,200 participants. The study started on 2025-06-11. Estimated completion is 2026-06.
What conditions does trial NCT06482450 study?
This clinical trial studies the following conditions: Vaccine Hesitancy, Vaccine Refusal.
What interventions are being tested in trial NCT06482450?
The interventions under investigation include: LetsTalkShots (patient-facing CDS) (OTHER), LetsTalkShots (provider-facing CDS) (OTHER), Appointment Reminder Message (OTHER).
Who is sponsoring clinical trial NCT06482450?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06482450 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaccine Hesitancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Communication Strategies to Increase HPV Vaccination Intention
RECRUITING · NA
-
RADx-UP Phase 3D (Oregon Saludable: Juntos Podemos)
ACTIVE NOT RECRUITING · NA
-
COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease
COMPLETED · NA
-
Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups
RECRUITING
-
Vaccine Hesitancy: A Survey of Pediatric Clinicians
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI